Roche Pharma India today announced the successful completion of the first phase of its Advanced Inclusive Research (AIR) Site Alliance initiative in India, having partnered with 10 leading government hospitals from across the country and trained...
One of the global pharmaceutical companies, Wockhardt Ltd., has signed and empowered Shukra Pharmaceuticals Limited to be the agent, distributor and manager for the evolved anti-infective products
Schneider Electric, the global specialist in digital energy management and automation, has partnered with Apollo Hospitals, Asia's broadest integrated healthcare provider, to boost energy reliability at Apollo Proton Cancer Centre (APCC) in Chennai..
Amit Agrawal, Secretary, Department of Pharmaceuticals (DoP), Ministry of Chemicals & Fertilizers, Government of India (GoI), highlighted the quantum jump by Indian Medical Devices sector and reiterated commitment to support the industry...
Alembic Pharmaceuticals (Alembic) announced the receipt of final approval by the US Food & Drug Administration
Baxdrostat is a new blood pressure medication created by AstraZeneca that has been seen to lower the risk of cardiovascular in patients with resistant hypertension
Strides Pharma Science announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte. Singapore, has signed an agreement with Kenox Pharmaceuticals, a high-growth contract development and manufacturing organization with a focus on..
India's prominent drug manufacturers Sun Pharmaceutical Industries and Lupin Ltd are advancing toward making affordable anti-obesity pills as the country faces a rapidly growing obesity epidemic. According to a report, the Drugs Controller General...
In this modern age of Artificial Intelligence, it is important to provide the new age AI driven solutions to the society in the healthcare sector also. In a strategic move to strengthen healthcare innovation in India
Eli Lilly and Company has been given the Breakthrough Therapy designation by the U.S. Food and Drug Administration (FDA) for olomorasib combined with anti-PD-1 therapy Keytruda